2
16
Eversense E3 CGM User Guide
The sensor has a silicone ring that contains a small amount of an anti-inflammatory drug (dexamethasone acetate).
It has not been determined whether the risks associated with injectable dexamethasone acetate apply to the
dexamethasone acetate elution ring inside the sensor. The elution ring releases a small amount of dexamethasone
acetate when the sensor comes in contact with body fluids and serves to minimise the body’s inflammatory response
to the inserted sensor. Dexamethasone acetate in the ring may also cause other adverse events not previously seen
with the injectable form. For a listing of potentially adverse eects related to dexamethasone acetate, contact your
healthcare provider.
Unauthorised modifications of the equipment, improperly accessing information within it or “jailbreaking” your
system, and taking any other unauthorised actions may cause the CGM system to malfunction and may put you
at risk. Unauthorised modification of the equipment is not permitted and voids your warranty.
Any serious incident that has occurred relating to use of the device should be reported to the manufacturer and
the competent authority of your Member State.
16
Eversense E3 CGM User Guide
2
To Next Page
Loading...
